U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - November 30, 2007
On December 1, people around the globe will commemorate World AIDS Day. More than 25 million men, women and children have already died, and an estimated 33.2 million people around the world are currently living with HIV infection. Each day, another 6,800 people become infected. Last year alone, an estimated 2.5 million
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Drug Abuse (NIDA) - Tuesday, November 27, 2007
Contact: Dorie Hightower or Sara Rosario Wilson, 301-443-6245, , Contacto en Espaņol: 301-594-6145
Award intended to stimulate scientists of exceptional creativity to study concepts and approaches in the forefront of drug abuse and HIV/AIDS research The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), announced today it is looking for scientists of exceptional creativity to a
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; John E. Fogarty International Center (FIC) - Monday, October 22, 2007
CONTACT: Ann Puderbaugh, 301-496-2075,
The National Institutes of Health today is hosting the launch of the Council of Science Editors global theme issue on poverty and human development, to coincide with the publication of related research by more than 230 journals worldwide. Seven of the most outstanding articles examining interventions and projects to im
National Institutes Of Health - September 15, 2007
Contact: Patricia Conrad
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), has been awarded the 2007 Mary Woodard Lasker Award for Public Service for his role in developing two major U.S. public health programs, in AIDS and biodefense. The award wil
U.S. Department of Health and Human Services; National Institutes Of Health: NIH News: National Cancer Institute (NCI) - Saturday, September 1, 2007
CONTACT: NCI Press Officers, , 301-496-6641
Several protease inhibitors that are used in combination with other drugs to treat Human Immunodeficiency Virus (HIV) infection may also be effective against certain types of cancer, according to researchers from the National Cancer Institute (NCI), part of the National Institutes of Health. Nelfinavir (
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Aging (NIA) - Wednesday, August 22, 2007
CONTACT: Linda Joy or Susan Farrer, 301-496-1752,
A majority of older Americans are sexually active and view intimacy as an important part of life, despite a high rate of bothersome sexual problems, according to a new report in the Aug. 23, 2007, issue of The New England Journal of Medicine . The findings come from the National Social Life, Health and Aging Project, r
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of General Medical Sciences (NIGMS); National Center on Minority Health and Health Disparities (NCMHD) - Tuesday, July 24, 2007
CONTACT: Lori Mulligan, 301-435-0897,
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will initially provide $9.5 million over three years to launch a Translational Research Network that will increase the opportunity for multi-site clinical and translational research among minority an
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Nursing Research (NINR) - Tuesday, June 26, 2007
CONTACT: Ray Bingham, 301-594-8011, e-mail:binghamr@mail.nih.gov
A brief skill-building program on practices to reduce exposure to sexually transmitted disease (STD) and HIV improved the self-reported protective behaviors of inner-city black women for up to one year and actually decreased their risk of acquiring an STD, according to a study appearing in the June 2007 issue of the Am
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, May 8, 2007
U.S. and Indian health officials have renewed the Indo-U.S. Vaccine Action Program (VAP), a 20-year-old bilateral collaboration supporting research on vaccines, immunology and related biomedical issues. The VAP aims to reduce the burden of vaccine-preventable diseases of public health significance in India, the
U.S. Department of Health and Human Services; National Institutes Of Health, NIH News; National Institute on Drug Abuse (NIDA) - Tuesday, May 8, 2007
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245, e-mail: media@nida.nih.gov, Contacto en Espanol: 301-594-6145
More than 500 scientists, clinicians and public health specialists met today at the National Institutes of Health (NIH) to discuss the latest research on drug abuse and the evolving epidemic of HIV/AIDS. This is the first-ever two-day public meeting at NIH to include a focus on non-injection drug use and HIV transmissi
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Cancer Institute (NCI) - Thursday, May 3, 2007
CONTACT: NCI Office of Media Relations, 301-496-6641,
An advanced imaging technique known as electron tomography has allowed researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to visualize an entry claw, a unique structure formed between the human immunodeficiency virus (HIV) that causes AIDS and the cell it infects. The f
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Sunday, April 15, 2007
CONTACT: NIAID News Office, 301-402-1663,
Immunologist and AIDS researcher Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), has been awarded the 2007 George M. Kober Medal of the Association of American Physicians (AAP) for his outstanding contributions to academic
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Human Genome Research Institute (NHGRI) - Thursday, April 12, 2007
CONTACT: Geoff Spencer, 301-402-0911,
An international consortium of researchers has published the genome sequence of the rhesus macaque monkey and aligned it with the chimpanzee and human genomes. Published April 13 in a special section of the journal Science , the analysis reveals that the three primate species share about 93 percent of their DNA, yet ha
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is holding a two day meeting to explore wide-ranging issues related to drug abuse, impaired decision making, and HIV/AIDS. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS will provide a broad understanding of
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; NIH Office of the Director (OD); NIH Office Of Technology Transfer (OTT)- Tuesday, April 3, 2007
CONTACT: Mark Rohrbaugh, 301-594-7700, , Alain Guedon, Institut Pasteur, EVP Business Development, +33672754162
The National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, and Institut Pasteur (IP), a private non-profit foundation, announced today an agreement to extend their long-standing collaboration in health research and the management of inventions arising from this research. The
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, January 11, 2007
Researchers have decoded the genetic makeup of the parasite that causes trichomoniasis, one of the most common sexually transmitted infections (STIs), revealing potential clues as to why the parasite has become increasingly drug resistant and suggesting possible pathways for new treatments, diagnostics and a potential
National Institutes Of Health; National Institute of Child Health and Human Development (NICHD); Fogarty International Center (FIC) - Wednesday, January 10, 2007
Robert Bock or Marianne Glass Miller, 301-496-5133, e-mail: bockr@mail.nih.gov
A woman s response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.) Conversely
This information is designed to support, not replace, the relationship that exists between you and your doctor.